PRESS RELEASE published on 12/03/2025 at 21:30, 1 day 6 hours ago Inside Information / News release on accounts, results Pierre & Vacances-Center Parcs confirms growth momentum in 2025 with robust financial performance, expanded portfolio, and enhanced customer satisfaction. Upbeat 2026 outlook with increased bookings and adjusted EBITDA guidance out to 2030 Financial Results Customer Satisfaction Growth Momentum 2026 Outlook Pierre & Vacances-Center Parcs
BRIEF published on 11/07/2025 at 11:24, 27 days 17 hours ago Pierre & Vacances Reports on Shares and Voting Rights Voting Rights French Commercial Code Shares Regulatory Disclosure Pierre & Vacances
PRESS RELEASE published on 11/07/2025 at 11:19, 27 days 17 hours ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Pierre et Vacances provides regulated information on total shares and voting rights as per French regulations Voting Rights French Regulations Regulated Information Total Shares Pierre Et Vacances
BRIEF published on 10/08/2025 at 11:32, 1 month 27 days ago Pierre & Vacances Publishes Voting Rights and Share Capital Details Share Capital Voting Rights French Regulations Treasury Shares Pierre Et Vacances
PRESS RELEASE published on 10/08/2025 at 11:27, 1 month 27 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital PIERRE ET VACANCES reports total number of shares and voting rights as of September 30, 2025, in compliance with French regulations Voting Rights Shares French Regulations Pierre Et Vacances
BRIEF published on 08/07/2025 at 14:59, 3 months 28 days ago Declaration of voting rights of Pierre et Vacances as of July 31, 2025 Share Capital Voting Rights Actions General Meeting Pierre Et Vacances Group
PRESS RELEASE published on 08/07/2025 at 14:54, 3 months 28 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Pierre et Vacances reports total number of shares and voting rights as of July 31, 2025, in accordance with regulatory requirements Voting Rights Shares Regulatory Compliance Financial Disclosure Pierre Et Vacances
BRIEF published on 06/18/2025 at 08:35, 5 months 16 days ago Pierre & Vacances-Center Parcs Group Reviews Strategic Options Financial Advisors Strategic Review Pierre & Vacances EBITDA Target ReInvention Plan
PRESS RELEASE published on 06/18/2025 at 08:30, 5 months 16 days ago Inside Information / Other news releases Pierre & Vacances-Center Parcs Group launches strategic review after successful 'ReInvention' plan. Financial advisors appointed for analysis and potential changes in shareholder structure Financial Advisors Strategic Options Shareholder Structure Review Pierre & Vacances
BRIEF published on 06/05/2025 at 11:46, 5 months 29 days ago Pierre et Vacances Group: Report on Voting Rights and Share Capital Share Capital Voting Rights Actions Regulation General Meeting
Published on 12/05/2025 at 02:35, 1 hour 54 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 29 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 24 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 29 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 58 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 38 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 3 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 14 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 18 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 29 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 44 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 44 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 28 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
